Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations

Online download statistics by month:

Online download statistics by month: February 2022 to March 2024

	Abstract	Full	Pdf
Feb 2022	751	793	197
Mar 2022	274	284	113
Apr 2022	197	214	90
May 2022	134	139	51
Jun 2022	135	140	41
Jul 2022	131	131	17
Aug 2022	133	135	22
Sep 2022	110	113	32
Oct 2022	120	127	47
Nov 2022	110	110	41
Dec 2022	98	98	22
Jan 2023	67	67	22
Feb 2023	84	85	30
Mar 2023	33	36	20
Apr 2023	42	44	36
May 2023	38	38	16
Jun 2023	43	43	17
Jul 2023	26	26	18
Aug 2023	33	33	15
Sep 2023	34	34	7
Oct 2023	26	26	11
Nov 2023	62	62	9
Dec 2023	58	58	27
Jan 2024	43	44	27
Feb 2024	59	59	31
Mar 2024	51	53	56
Total	2892	2992	1015